Lumbar Spinal Stenosis: Pathophysiology, Biomechanics, and Innovations in Diagnosis and Management.

Journal of spine research and surgery Pub Date : 2025-01-01 Epub Date: 2025-02-18 DOI:10.26502/fjsrs0082
Alexander Abdou, Samuel Kades, Tariq Masri-Zada, Syed Asim, Mo'men Bany-Mohammed, Devendra K Agrawal
{"title":"Lumbar Spinal Stenosis: Pathophysiology, Biomechanics, and Innovations in Diagnosis and Management.","authors":"Alexander Abdou, Samuel Kades, Tariq Masri-Zada, Syed Asim, Mo'men Bany-Mohammed, Devendra K Agrawal","doi":"10.26502/fjsrs0082","DOIUrl":null,"url":null,"abstract":"<p><p>Lumbar spinal stenosis (LSS) is a common condition caused by the narrowing of the spinal canal, resulting in compression of neural and vascular structures. This compression leads to symptoms such as claudication, paresthesia, and lower extremity weakness. LSS is the leading cause of low back pain and functional limitations, affecting over 103 million people worldwide. Degenerative changes, including ligamentum flavum hypertrophy, facet joint osteoarthritis, and intervertebral disc degeneration, are the primary contributors to LSS. Additional factors, such as genetic predisposition, congenital abnormalities, and autoimmune conditions, are also emerging as contributors. A major challenge in managing LSS lies in differentiating it from other causes of neurogenic symptoms and low back pain while devising an appropriate treatment plan from the wide array of conservative and surgical options available. Minimally invasive surgical techniques, such as lumbar spinous process-splitting laminoplasty and partial facetectomy, are often compared to the gold standard laminectomy with or without fusion. Surgical interventions offer significant improvements in pain relief, disability, and quality of life within 3-6 months; however, these benefits often diminish after 2-4 years. Contrasting evidence demonstrates that long-term outcomes of non-surgical treatments, such as physical therapy, pharmacological management, and lifestyle modifications, are often comparable to surgical modalities. Emerging therapies, including interspinous devices and stem cell therapy, show promise but require further research. Managing LSS requires a multidisciplinary approach tailored to patient-specific factors, including age, comorbidities, and functional goals. Future research should aim to improve diagnostic accuracy, refine surgical techniques, and explore innovative therapies to enhance outcomes for patients with LSS.</p>","PeriodicalId":73951,"journal":{"name":"Journal of spine research and surgery","volume":"7 1","pages":"1-17"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11906179/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of spine research and surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/fjsrs0082","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/18 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Lumbar spinal stenosis (LSS) is a common condition caused by the narrowing of the spinal canal, resulting in compression of neural and vascular structures. This compression leads to symptoms such as claudication, paresthesia, and lower extremity weakness. LSS is the leading cause of low back pain and functional limitations, affecting over 103 million people worldwide. Degenerative changes, including ligamentum flavum hypertrophy, facet joint osteoarthritis, and intervertebral disc degeneration, are the primary contributors to LSS. Additional factors, such as genetic predisposition, congenital abnormalities, and autoimmune conditions, are also emerging as contributors. A major challenge in managing LSS lies in differentiating it from other causes of neurogenic symptoms and low back pain while devising an appropriate treatment plan from the wide array of conservative and surgical options available. Minimally invasive surgical techniques, such as lumbar spinous process-splitting laminoplasty and partial facetectomy, are often compared to the gold standard laminectomy with or without fusion. Surgical interventions offer significant improvements in pain relief, disability, and quality of life within 3-6 months; however, these benefits often diminish after 2-4 years. Contrasting evidence demonstrates that long-term outcomes of non-surgical treatments, such as physical therapy, pharmacological management, and lifestyle modifications, are often comparable to surgical modalities. Emerging therapies, including interspinous devices and stem cell therapy, show promise but require further research. Managing LSS requires a multidisciplinary approach tailored to patient-specific factors, including age, comorbidities, and functional goals. Future research should aim to improve diagnostic accuracy, refine surgical techniques, and explore innovative therapies to enhance outcomes for patients with LSS.

腰椎管狭窄:病理生理学,生物力学,以及诊断和管理的创新。
腰椎管狭窄症(LSS)是由椎管狭窄引起的一种常见疾病,导致神经和血管结构受到压迫。这种压迫导致跛行、感觉异常和下肢无力等症状。LSS是腰痛和功能限制的主要原因,影响全球超过1.03亿人。退行性改变,包括黄韧带肥大、小关节骨关节炎和椎间盘退变,是LSS的主要诱因。其他因素,如遗传易感性、先天性异常和自身免疫性疾病,也正在成为影响因素。管理LSS的主要挑战在于将其与其他神经源性症状和腰痛的原因区分开来,同时从广泛的保守和手术选择中制定适当的治疗计划。微创手术技术,如腰椎棘突劈开椎板成形术和部分面部切除术,经常与金标准椎板切除术进行比较,有无融合。手术干预可在3-6个月内显著改善疼痛缓解、残疾和生活质量;然而,这些好处通常在2-4年后就会消失。对比证据表明,非手术治疗的长期结果,如物理治疗、药物管理和生活方式改变,通常与手术方式相当。新兴疗法,包括棘间装置和干细胞疗法,显示出希望,但需要进一步的研究。管理LSS需要针对患者的具体因素,包括年龄、合并症和功能目标,采用多学科方法。未来的研究应旨在提高诊断准确性,改进手术技术,探索创新疗法,以提高LSS患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信